Yousif Capital Management LLC Has $2.67 Million Stake in Masimo Co. (NASDAQ:MASI)

Yousif Capital Management LLC reduced its holdings in Masimo Co. (NASDAQ:MASI) by 3.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 16,155 shares of the medical equipment provider’s stock after selling 582 shares during the period. Yousif Capital Management LLC’s holdings in Masimo were worth $2,670,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. FMR LLC lifted its stake in shares of Masimo by 41.2% in the 3rd quarter. FMR LLC now owns 6,756,618 shares of the medical equipment provider’s stock valued at $900,860,000 after purchasing an additional 1,970,883 shares during the period. Westfield Capital Management Co. LP lifted its stake in Masimo by 23.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,394,056 shares of the medical equipment provider’s stock valued at $185,869,000 after buying an additional 262,370 shares during the period. Assenagon Asset Management S.A. boosted its holdings in Masimo by 916.1% during the fourth quarter. Assenagon Asset Management S.A. now owns 216,051 shares of the medical equipment provider’s stock worth $35,713,000 after buying an additional 194,788 shares during the last quarter. Clearline Capital LP acquired a new position in shares of Masimo during the 3rd quarter worth about $21,337,000. Finally, ING Groep NV raised its position in shares of Masimo by 143.3% in the 3rd quarter. ING Groep NV now owns 240,900 shares of the medical equipment provider’s stock valued at $32,119,000 after acquiring an additional 141,900 shares during the period. 85.96% of the stock is owned by institutional investors.

Masimo Stock Performance

MASI opened at $176.16 on Monday. The business’s 50-day moving average price is $171.63 and its two-hundred day moving average price is $147.10. Masimo Co. has a 1 year low of $101.61 and a 1 year high of $183.14. The company has a market capitalization of $9.43 billion, a price-to-earnings ratio of 121.49 and a beta of 1.02. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Piper Sandler boosted their price objective on shares of Masimo from $180.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, December 18th. Stifel Nicolaus reissued a “buy” rating and issued a $190.00 price target (up previously from $170.00) on shares of Masimo in a report on Friday, November 22nd. Wells Fargo & Company raised their price objective on Masimo from $171.00 to $193.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research note on Wednesday, January 22nd. Finally, Raymond James raised their price target on Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a research report on Friday, December 27th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, Masimo currently has an average rating of “Moderate Buy” and an average target price of $191.40.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.